Health
New Alzheimer’s drug aducanumab is dividing doctors and patients, as the TGA weighs up its risk-benefit profile – ABC News
The first new Alzheimer’s drug approved by US regulators in almost two decades is generating global interest and global controversy….
After a decades-long career as a biology teacher, John Rodgers applies the strict logic of a scientist to answer tough questions.
So, when it comes to his mortality, he is equally rational.
“I either want it to end quickly or get better,” he said.
Key points:
…
-
Business19 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General23 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General19 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General19 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts